Table 4.
Etiologic agents of pneumonia in immunocompromised hosts
| Organism | Comment |
|---|---|
| Pneumocystis jaroveci | Previously called Pneumocystis carinii; associated with cellular immune defects, including HIV infection; typically seen when CD4 count is less than 200 cells/mm3 or in infants from 3 – 6 months of age |
| Cryptococcus neoformans | Yeast; intrinsically resistant to caspofungin |
| Candida spp | May be part of disseminated deep-organ infection |
| Aspergillus spp | Common cause of nodular lung infection |
| Zygomycetes | Family of fungi that includes Rhizopus, Mucor, and others; may be resistant to amphotericin B |
| Nocardia spp | Environmental bacteria; commonly cause infection of lungs, brain, or skin; require long-term therapy |
| Cytomegalovirus | Pneumonia as part of disseminated disease |
| Herpes simplex virus and varicella-zoster virus | Pneumonia as part of disseminated disease |
| Encapsulated bacteria (S. pneumoniae, H. influenzae, Salmonella spp) | Respiratory infections in asplenic hosts or hosts with humoral immune defects |
| Nosocomial bacteria, including Pseudomonas or enteric gram-negative rods | Consider as cause of pneumonia in neutropenic patients; may be seen in association with central venous catheter infections |